Related references
Note: Only part of the references are listed.Preclinical studies of celastrol and acetyl lsogambogic acid in melanoma
Sabiha Abbas et al.
CLINICAL CANCER RESEARCH (2007)
Suppression of p53-dependent senescence by the JNK signal transduction pathway
Madhurnita Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression of activated Akt in benign nevi, Spitz nevi and melanomas
Sara M. Kantrow et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases:: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
Barry R. Davies et al.
MOLECULAR CANCER THERAPEUTICS (2007)
JAK-STAT signaling: From interferons to cytokines
Christian Schindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Development of IFN-γ resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells
M. Fojtova et al.
BRITISH JOURNAL OF CANCER (2007)
The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition
Samudra K. Dissanayake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment
F. Meier et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Confirmation of a BRAF mutation-associated gene expression signature in melanoma
Peter Johansson et al.
PIGMENT CELL RESEARCH (2007)
Notch signaling in development and cancer
Victoria Bolos et al.
ENDOCRINE REVIEWS (2007)
Rewired ERK-JNK signaling pathways in melanoma
Pablo Lopez-Bergami et al.
CANCER CELL (2007)
The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics
Michalis V. Karamouzis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells
T. S. Khatlani et al.
ONCOGENE (2007)
JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas
Odette Mariani et al.
CANCER CELL (2007)
Mutant V600E BRAF increases hypoxia inducible factor-1α expression in melanoma
Suresh M. Kumar et al.
CANCER RESEARCH (2007)
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth
Yu-Ching Lin et al.
HUMAN GENE THERAPY (2007)
Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells
J. Liu et al.
ONCOGENE (2007)
Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
Baskaran Govindarajan et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNα2b
Wenjun Wang et al.
CLINICAL CANCER RESEARCH (2007)
The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types
M-A Forget et al.
BRITISH JOURNAL OF CANCER (2007)
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma
Janiel M. Shields et al.
CANCER RESEARCH (2007)
mda-9/syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-κB
Habib Boukerche et al.
CANCER RESEARCH (2007)
Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells
K. V. Bhatt et al.
ONCOGENE (2007)
The many ways of Wnt in cancer
Paul Polakis
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Dickkopf-1 activates cell death in MDA-MB435 melanoma cells
Andrei M. Mikheev et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
Xinjiang Wang et al.
CELL (2007)
Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions
Rajendra S. Singh et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1
Christina Nielsen et al.
CANCER RESEARCH (2007)
Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited
Vanessa C. Gray-Schopfer et al.
CANCER RESEARCH (2007)
The JNK signal transduction pathway
Claire R. Weston et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Multiplicity of the interactions of Wnt proteins and their receptors
Akira Kikuchi et al.
CELLULAR SIGNALLING (2007)
Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain
Claudia Mertens et al.
GENES & DEVELOPMENT (2006)
The microphthalmia-associated transcription factor Mitf interacts with β-catenin to determine target gene expression
Alexander Schepsky et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Molecularly targeted therapy for melanoma - Current reality and future options
Juergen C. Becker et al.
CANCER (2006)
c-Jun NH2-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells
Jian Cui et al.
CANCER RESEARCH (2006)
STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases
Alireza Mirmohammadsadegh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression
Laurie S. Spofford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding
Dylan T. Jones et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Prognostic significance of nuclear factor-kB p105/p50 in human melanoma and its role in cell migration
Kai Gao et al.
CANCER RESEARCH (2006)
Expression of Dickkopf genes is strongly reduced in malignant melanoma
S. Kuphal et al.
ONCOGENE (2006)
Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases
Arati Sharma et al.
CANCER RESEARCH (2006)
BRAF and NRAS mutations in melanoma and melanocytic nevi
Jenny N. Poynter et al.
MELANOMA RESEARCH (2006)
The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Hidetoshi Sumimoto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Epigenetic silencing of the PTEN gene in melanoma
Alireza Mirmohammadsadegh et al.
CANCER RESEARCH (2006)
PI3-kinase subunits are infrequent somatic targets in melanoma
John A. Curtin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer
Marije M. Vleugel et al.
HUMAN PATHOLOGY (2006)
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
KSM Smalley et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors
H Richly et al.
ANNALS OF ONCOLOGY (2006)
Nuclear factor inducing kinase:: A key regulator in osteopontin-induced MAPK/IκB kinase dependent NF-κB-mediated promatrix metalloproteinase-9 activation
Hema Rangaswami et al.
GLYCOCONJUGATE JOURNAL (2006)
Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells
Lourdes A. Gomez et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression
ZJ Liu et al.
CANCER RESEARCH (2006)
Molecular targets in melanoma from angiogenesis to apoptosis
JA Sosman et al.
CLINICAL CANCER RESEARCH (2006)
Mutations of PIK3CA are rare in cutaneous melanoma
K Omholt et al.
MELANOMA RESEARCH (2006)
Genetic alterations in signaling pathways in melanoma
FG Haluska et al.
CLINICAL CANCER RESEARCH (2006)
Activation of Stat3 in human melanoma promotes brain metastasis
TX Xie et al.
CANCER RESEARCH (2006)
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma
P Hersey
CURRENT OPINION IN ONCOLOGY (2006)
Wnt signaling: complexity at the surface
KM Cadigan et al.
JOURNAL OF CELL SCIENCE (2006)
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma
D Massi et al.
MODERN PATHOLOGY (2006)
Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi
H Sumimoto et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Oncogenic BRAF is required for tumor growth and maintenance in melanoma models
MP Hoeflich et al.
CANCER RESEARCH (2006)
The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation
B Bedogni et al.
CANCER CELL (2005)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Activation of Notch1 signaling is required for β-catenin-mediated human primary melanoma progression
K Balint et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
STAT5 contributes to interferon resistance of melanoma cells
C Wellbrock et al.
CURRENT BIOLOGY (2005)
Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model
M Uhlirova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies
PM LoRusso et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Receptor for RACK1 mediates activation of JNK by protein kinase C
P Lopez-Bergami et al.
MOLECULAR CELL (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity
BY Choi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
R Buscà et al.
JOURNAL OF CELL BIOLOGY (2005)
Transforming growth factor-β and malignant melanoma:: molecular mechanisms
MR Hussein
JOURNAL OF CUTANEOUS PATHOLOGY (2005)
SKI pathways inducing progression of human melanoma
JA Reed et al.
CANCER AND METASTASIS REVIEWS (2005)
Targeting STAT3 affects melanoma on multiple fronts
M Kortylewski et al.
CANCER AND METASTASIS REVIEWS (2005)
Role of nuclear factor-κB in melanoma
KI Amiri et al.
CANCER AND METASTASIS REVIEWS (2005)
ATM-dependent phosphorylation of ATF2 is required for the DNA damage response
A Bhoumik et al.
MOLECULAR CELL (2005)
Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival
E Grafström et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases
DL Dai et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Wnt pathway activation: New relations and locations
A Bejsovec
CELL (2005)
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis
TX Xie et al.
ONCOGENE (2004)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
The role of protein kinase C-alpha (PKC-α) in melanoma
MM Lahn et al.
MELANOMA RESEARCH (2004)
Brn-2 expression controls melanoma proliferation and is directly regulated by β-catenin
J Goodall et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Absence of BRAF mutations in UV-protected mucosal melanomas
RH Edwards et al.
JOURNAL OF MEDICAL GENETICS (2004)
Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity
A Bhoumik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome
AT Weeraratna et al.
ONCOGENE (2004)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
Is there more than one road to melanoma?
JK Rivers
LANCET (2004)
Interferon-γ-mediated growth regulation of melanoma cells:: Involvement of STAT1-dependent and STAT1-independent signals
M Kortylewski et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells
AM Mingo-Sion et al.
ONCOGENE (2004)
High BRAF mutation frequency does not characterize all melanocytic tumor types
G Saldanha et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells
AR Uzgare et al.
CANCER RESEARCH (2004)
B-RAF is a therapeutic target in melanoma
M Karasarides et al.
ONCOGENE (2004)
Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference
H Sumimoto et al.
ONCOGENE (2004)
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells -: Role of BRAF mutation and fibroblast growth factor signaling
JT Huntington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
BRAF alterations are associated with complex mutational profiles in malignant melanoma
M Daniotti et al.
ONCOGENE (2004)
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth
L You et al.
CANCER RESEARCH (2004)
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas
K Hoek et al.
CANCER RESEARCH (2004)
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
O Distler et al.
CIRCULATION RESEARCH (2004)
The complexity of PTEN: mutation, marker and potential target for therapeutic intervention
LS Steelman et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Genetic and epigenetic alterations of the APC gene in malignant melanoma
J Worm et al.
ONCOGENE (2004)
Inhibition of melanoma growth and metastasis by ATF2-derived peptides
A Bhoumik et al.
CANCER RESEARCH (2004)
Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia
K Nakayama et al.
CELL (2004)
Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanoma
S Kuphal et al.
ONCOGENE (2004)
Microarray expression profiling in melanoma reveals a BRAF mutation signature
S Pavey et al.
ONCOGENE (2004)
Deregulated Akt3 activity promotes development of malignant melanoma
JM Stahl et al.
CANCER RESEARCH (2004)
Induction of MMP-10 and MMP-1 in a squamous cell carcinoma cell line by ultraviolet radiation
MC Ramos et al.
BIOLOGICAL CHEMISTRY (2004)
Opposite long-term regulation of c-Myc and p27Kip1through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells
G Lefevre et al.
ONCOGENE (2003)
Reciprocal regulation of MelCAM and AKT in human melanoma
G Li et al.
ONCOGENE (2003)
A second canon:: Functions and mechanisms of β-catenin-independent wnt signaling
MT Veeman et al.
DEVELOPMENTAL CELL (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
Lack of BRAF mutation in primary uveal melanoma
Y Cohen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis
M Krasilnikov et al.
ONCOGENE (2003)
Gene-expression profiling in human cutaneous melanoma
KM Carr et al.
ONCOGENE (2003)
Death receptors and melanoma resistance to apoptosis
VN Ivanov et al.
ONCOGENE (2003)
PTEN signaling pathways in melanoma
H Wu et al.
ONCOGENE (2003)
Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas
SC Edmunds et al.
BRITISH JOURNAL OF CANCER (2003)
A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
KSM Smalley
INTERNATIONAL JOURNAL OF CANCER (2003)
Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation
DS Kim et al.
JOURNAL OF CELL SCIENCE (2003)
Osteopontin induces nuclear factor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways
S Philip et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Suppression of Ras-stimulated transformation by the JNK signal transduction pathway
NJ Kennedy et al.
GENES & DEVELOPMENT (2003)
Tissue microarray-based analysis shows phospho-β-catenin expression in malignant melanoma is associated with poor outcome
E Kielhorn et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53
R Eferl et al.
CELL (2003)
Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines
Y Ishii et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Suppressors of cytokine signaling and immunity
M Kubo et al.
NATURE IMMUNOLOGY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
NF-κB signaling:: Many roads lead to Madrid
V Dixit et al.
CELL (2002)
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
G Niu et al.
ONCOGENE (2002)
β-Catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor
HR Widlund et al.
JOURNAL OF CELL BIOLOGY (2002)
An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis
A Bhoumik et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Molecular genetic analysis of malignant melanomas for aberrations of the Wnt signaling pathway genes CTNNB1, APC, ICAT and BTRC
J Reifenberger et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Stat proteins and oncogenesis
J Bromberg
JOURNAL OF CLINICAL INVESTIGATION (2002)
Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma
DC Whiteman et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The protein kinase B/Akt signalling pathway in human malignancy
KM Nicholson et al.
CELLULAR SIGNALLING (2002)
Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells
GB Tower et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
AT Weeraratna et al.
CANCER CELL (2002)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells
P Dhawan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling
VN Ivanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1
JA Recio et al.
ONCOGENE (2002)
Absence of mutations in the pleckstrin homology (PH) domain of protein kinase B (PKB/Akt) in malignant melanoma
V Waldmann et al.
MELANOMA RESEARCH (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Gene expression profiles of pancreatic cancer and stromal desmoplasia
T Crnogorac-Jurcevic et al.
ONCOGENE (2001)
Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene
PH Hwang et al.
CANCER LETTERS (2001)
Constitutive activation of Wnt/β-catenin signaling pathway in migration-active melanoma cells:: Role of LEF-1 in melanoma with increased metastatic potential
T Murakami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Analysis of K-ras, APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis
T Takayama et al.
GASTROENTEROLOGY (2001)
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
D Kim et al.
FASEB JOURNAL (2001)
Blocking oncogenic Ras signaling for cancer therapy
AA Adjei
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor snail
I Poser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutations of the activation-associated phosphorylation sites at codons 308 and 473 of protein kinase B are absent in human melanoma
V Waldmann et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2001)
Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells
M Kortylewski et al.
BIOCHEMICAL JOURNAL (2001)
Cytoplasmic and nuclear accumulation of β-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma
K Omholt et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
LV Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Induction of β3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway
D Woods et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Function and regulation of AP-1 subunits in skin physiology and pathology
P Angel et al.
ONCOGENE (2001)
Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
Y Chinenov et al.
ONCOGENE (2001)
Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis
H van Dam et al.
ONCOGENE (2001)
Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFα and suppression of NF-κB activities
VN Ivanov et al.
ONCOGENE (2001)
Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway
D Koul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Stat family in cytokine signaling
JN Ihle
CURRENT OPINION IN CELL BIOLOGY (2001)
Cooperation between STAT3 and c-Jun suppresses Fas transcription
VN Ivanov et al.
MOLECULAR CELL (2001)
Nuclear factor-κB activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway
DZ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
XP Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Identification of PTEN mutations in metastatic melanoma specimens
JT Çelebi et al.
JOURNAL OF MEDICAL GENETICS (2000)
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner et al.
NATURE (2000)
Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-β1 in transformed keratinocytes
JF Santibáñez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The Wnt/Ca2+ pathway -: a new vertebrate Wnt signaling pathway takes shape
M Kühl et al.
TRENDS IN GENETICS (2000)
Translocation of TRAF proteins regulates apoptotic threshold of cells
RH Arch et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression
VN Ivanov et al.
ONCOGENE (2000)
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
A Behrens et al.
ONCOGENE (2000)
Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a
K Takeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas
J Reifenberger et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis
VN Ivanov et al.
ONCOGENE (2000)
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies
A Birck et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
